LP
FPRX

LMR Partners’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

LMR Partners’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-117,397
Closed -$4.42M – 1588
2021
Q1 		$4.42M Buy
+117,397
New +$2.93M 0.11% 171

LMR Partners's FPRX Position: Q2 2021 in Review

LMR Partners sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 117,397 shares — an estimated $4.42M sold.

LMR Partners first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $4.42M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • LMR Partners reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • LMR Partners sold 117,397 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $4.42M.
  • LMR Partners first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
  • LMR Partners's Five Prime Therapeutics, Inc. position peaked at $4.42M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on LMR Partners's 13F filing for Q2 2021, filed 16 Aug 2021.